Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 11/2009

01-11-2009 | Case Report

Case Reports—Resolution of Barrett’s Disease and Esophageal Epithelial Atypia After Gastric Bypass and LAP-BAND

Authors: Craig G. Chang, Edward Perez

Published in: Obesity Surgery | Issue 11/2009

Login to get access

Abstract

Gastroesophageal reflux is a well-recognized complication of obesity. Long-term reflux is associated with the progression from esophageal injury to Barrett’s esophagus then to carcinoma. Bariatric surgery may prevent reflux and the progression of esophageal injury. We present two cases that had remission of their esophageal problems after differing bariatric operations.
Literature
1.
Houghton SG, Romero Y, Sarr MG. Effect of Roux-en-Y gastric bypass in obese patients with Barrett’s esophagus: attempts to eliminate duodenogastric reflux. Surg Obes Relat Dis. 2008;4:1–5.CrossRef
2.
Csendes A, Burgos AM, Smok G, et al. Effect of gastric bypass on Barrett’s esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg. 2006;10:259–64.CrossRef
3.
Cobey F, Oelschlager B. Complete regression of Barrett’s esophagus after Roux-en-Y gastric bypass. Obes Surg. 2005;15:710–2.CrossRef
4.
Csendes A, Smok G, Burdiles P, et al. Prevalence of Barrett’s esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus. 2000;13:5–11.CrossRef
5.
Kanthan R, Torkian B, Kanthan SC. Pathological validity of esophageal endoscopy. How real is what we see? Myth or reality? Dis Esophagus. 2004;17:304–6.CrossRef
6.
Voutilainen M, Farkkila M, Mecklin JP, et al. Classical Barrett esophagus contrasted with Barrett-type epithelium at normal-appearing esophagogastric junction. Central Finland Endoscopy Study Group. Scand J Gastroenterol. 2000;35:2–9.CrossRef
7.
Anagnostopoulos GK, Yao K, Kaye P. Novel endoscopic observation in Barrett’s oesophagus using high resolution magnification endoscopy and narrow band imaging. Aliment Pharmacol Ther. 2007;26:501–7.CrossRef
Metadata
Title
Case Reports—Resolution of Barrett’s Disease and Esophageal Epithelial Atypia After Gastric Bypass and LAP-BAND
Authors
Craig G. Chang
Edward Perez
Publication date
01-11-2009
Publisher
Springer New York
Published in
Obesity Surgery / Issue 11/2009
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-009-9974-8

Other articles of this Issue 11/2009

Obesity Surgery 11/2009 Go to the issue

Clinical Report

Laparoscopic Gastric Bypass in Patients 60 Years and Older: Early Postoperative Morbidity and Resolution of Comorbidities

Clinical Research

Effects of Gastric Band Adjustments on Intraluminal Pressure

Other

Cost-effectiveness and Budget Impact of Obesity Surgery in Patients with Type 2 Diabetes in Three European Countries(II)

Research Article

Cost-Effective Restrictive Bariatric Surgery: Laparoscopic Vertical Banded Gastroplasty Versus Laparoscopic Adjustable Gastric Band

Clinical Research

Short-Term Morbidity and Mortality After Open Versus Laparoscopic Gastric Bypass Surgery. A Population-Based Study from Sweden

Clinical Report

Treatment with Sibutramine prior to Roux-en-Y Gastric Bypass leads to an Improvement of Metabolic Parameters and to a Reduction of Liver Size and Operative Time